Central leptin and tumor necrosis factor-α (TNFα) in diurnal control of blood pressure and hypertension

Cheng Han, Wenhe Wu, Albert Ale, Min Soo Kim, Dongsheng Cai

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Leptin and TNFα can individually work in the brain to affect blood pressure; however, it remains unknown whether these two cytokines might have an interactive role in this process and, if so, how. In this work, we found that leptin stimulation led to TNFα production under both in vitro and in vivo conditions, and diurnal fluctuation of leptin concentrations in the cerebrospinal fluid predicted the circadian changes of TNFα gene expression in the hypothalamus. Signaling analysis showed that leptin stimulation led to a rapid and strong STAT3 activation followed by a second-phase moderate STAT3 activation, which was selectively abolished by anti-inflammatory chemical PS1145 or TNFα antagonist WP9QY. Physiological study in normal mice revealed that diurnal rise of blood pressure was abrogated following central administration of PS1145 or a leptin receptor antagonist. Central TNFα pretreatment was found to potentiate the effect of leptin in elevating blood pressure in normal mice. In pathophysiology, dietary obesity mimicked TNFα pretreatment in promoting leptin-induced blood pressure rise, and this effect was blocked by central treatment with either PS1145 or WP9QY. Hence, central leptin employs TNFα to mediate the diurnal blood pressure elevation in physiology while enhancement of this mechanism can contribute to hypertension development.

Original languageEnglish (US)
Pages (from-to)15131-15142
Number of pages12
JournalJournal of Biological Chemistry
Volume291
Issue number29
DOIs
StatePublished - Jul 15 2016

Fingerprint

Blood pressure
Leptin
Tumor Necrosis Factor-alpha
Blood Pressure
Hypertension
Chemical activation
Cerebrospinal fluid
Leptin Receptors
Physiology
Gene expression
Hypothalamus
Cerebrospinal Fluid
Brain
Anti-Inflammatory Agents
Obesity
Cytokines
Gene Expression
PS1145

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Central leptin and tumor necrosis factor-α (TNFα) in diurnal control of blood pressure and hypertension. / Han, Cheng; Wu, Wenhe; Ale, Albert; Kim, Min Soo; Cai, Dongsheng.

In: Journal of Biological Chemistry, Vol. 291, No. 29, 15.07.2016, p. 15131-15142.

Research output: Contribution to journalArticle

Han, Cheng ; Wu, Wenhe ; Ale, Albert ; Kim, Min Soo ; Cai, Dongsheng. / Central leptin and tumor necrosis factor-α (TNFα) in diurnal control of blood pressure and hypertension. In: Journal of Biological Chemistry. 2016 ; Vol. 291, No. 29. pp. 15131-15142.
@article{0c42a31ca62b4c979b4b5520ce5e0c89,
title = "Central leptin and tumor necrosis factor-α (TNFα) in diurnal control of blood pressure and hypertension",
abstract = "Leptin and TNFα can individually work in the brain to affect blood pressure; however, it remains unknown whether these two cytokines might have an interactive role in this process and, if so, how. In this work, we found that leptin stimulation led to TNFα production under both in vitro and in vivo conditions, and diurnal fluctuation of leptin concentrations in the cerebrospinal fluid predicted the circadian changes of TNFα gene expression in the hypothalamus. Signaling analysis showed that leptin stimulation led to a rapid and strong STAT3 activation followed by a second-phase moderate STAT3 activation, which was selectively abolished by anti-inflammatory chemical PS1145 or TNFα antagonist WP9QY. Physiological study in normal mice revealed that diurnal rise of blood pressure was abrogated following central administration of PS1145 or a leptin receptor antagonist. Central TNFα pretreatment was found to potentiate the effect of leptin in elevating blood pressure in normal mice. In pathophysiology, dietary obesity mimicked TNFα pretreatment in promoting leptin-induced blood pressure rise, and this effect was blocked by central treatment with either PS1145 or WP9QY. Hence, central leptin employs TNFα to mediate the diurnal blood pressure elevation in physiology while enhancement of this mechanism can contribute to hypertension development.",
author = "Cheng Han and Wenhe Wu and Albert Ale and Kim, {Min Soo} and Dongsheng Cai",
year = "2016",
month = "7",
day = "15",
doi = "10.1074/jbc.M116.730408",
language = "English (US)",
volume = "291",
pages = "15131--15142",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "29",

}

TY - JOUR

T1 - Central leptin and tumor necrosis factor-α (TNFα) in diurnal control of blood pressure and hypertension

AU - Han, Cheng

AU - Wu, Wenhe

AU - Ale, Albert

AU - Kim, Min Soo

AU - Cai, Dongsheng

PY - 2016/7/15

Y1 - 2016/7/15

N2 - Leptin and TNFα can individually work in the brain to affect blood pressure; however, it remains unknown whether these two cytokines might have an interactive role in this process and, if so, how. In this work, we found that leptin stimulation led to TNFα production under both in vitro and in vivo conditions, and diurnal fluctuation of leptin concentrations in the cerebrospinal fluid predicted the circadian changes of TNFα gene expression in the hypothalamus. Signaling analysis showed that leptin stimulation led to a rapid and strong STAT3 activation followed by a second-phase moderate STAT3 activation, which was selectively abolished by anti-inflammatory chemical PS1145 or TNFα antagonist WP9QY. Physiological study in normal mice revealed that diurnal rise of blood pressure was abrogated following central administration of PS1145 or a leptin receptor antagonist. Central TNFα pretreatment was found to potentiate the effect of leptin in elevating blood pressure in normal mice. In pathophysiology, dietary obesity mimicked TNFα pretreatment in promoting leptin-induced blood pressure rise, and this effect was blocked by central treatment with either PS1145 or WP9QY. Hence, central leptin employs TNFα to mediate the diurnal blood pressure elevation in physiology while enhancement of this mechanism can contribute to hypertension development.

AB - Leptin and TNFα can individually work in the brain to affect blood pressure; however, it remains unknown whether these two cytokines might have an interactive role in this process and, if so, how. In this work, we found that leptin stimulation led to TNFα production under both in vitro and in vivo conditions, and diurnal fluctuation of leptin concentrations in the cerebrospinal fluid predicted the circadian changes of TNFα gene expression in the hypothalamus. Signaling analysis showed that leptin stimulation led to a rapid and strong STAT3 activation followed by a second-phase moderate STAT3 activation, which was selectively abolished by anti-inflammatory chemical PS1145 or TNFα antagonist WP9QY. Physiological study in normal mice revealed that diurnal rise of blood pressure was abrogated following central administration of PS1145 or a leptin receptor antagonist. Central TNFα pretreatment was found to potentiate the effect of leptin in elevating blood pressure in normal mice. In pathophysiology, dietary obesity mimicked TNFα pretreatment in promoting leptin-induced blood pressure rise, and this effect was blocked by central treatment with either PS1145 or WP9QY. Hence, central leptin employs TNFα to mediate the diurnal blood pressure elevation in physiology while enhancement of this mechanism can contribute to hypertension development.

UR - http://www.scopus.com/inward/record.url?scp=84978427533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978427533&partnerID=8YFLogxK

U2 - 10.1074/jbc.M116.730408

DO - 10.1074/jbc.M116.730408

M3 - Article

VL - 291

SP - 15131

EP - 15142

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 29

ER -